Cargando…

T329S Mutation in the FMO3 Gene Alleviates Lipid Metabolic Diseases in Chickens in the Late Laying Period

SIMPLE SUMMARY: The lipid deposition and health status of egg-laying hens is crucial to the development of the poultry industry. This study aimed to evaluate the effects of genetic variations in the flavin-containing monooxygenase 3 (FMO3) on the lipid metabolic diseases of laying hens during the la...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jianlou, Huang, Mingyi, Shi, Xuefeng, Li, Xianyu, Chen, Xia, He, Zhaoxiang, Li, Junying, Xu, Guiyun, Zheng, Jiangxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749748/
https://www.ncbi.nlm.nih.gov/pubmed/35011153
http://dx.doi.org/10.3390/ani12010048
_version_ 1784631304063549440
author Song, Jianlou
Huang, Mingyi
Shi, Xuefeng
Li, Xianyu
Chen, Xia
He, Zhaoxiang
Li, Junying
Xu, Guiyun
Zheng, Jiangxia
author_facet Song, Jianlou
Huang, Mingyi
Shi, Xuefeng
Li, Xianyu
Chen, Xia
He, Zhaoxiang
Li, Junying
Xu, Guiyun
Zheng, Jiangxia
author_sort Song, Jianlou
collection PubMed
description SIMPLE SUMMARY: The lipid deposition and health status of egg-laying hens is crucial to the development of the poultry industry. This study aimed to evaluate the effects of genetic variations in the flavin-containing monooxygenase 3 (FMO3) on the lipid metabolic diseases of laying hens during the late laying period. The results showed that the T329S mutation in FMO3 moderated the lipid parameters and decreased the atherosclerotic lesions and hepatic steatosis in laying hens with homozygous T329S mutation. In conclusion, the T329S mutation in FMO3 is closely associated with the improvement of lipid metabolic diseases in laying hens during the late laying period. The results of this study may contribute to overcoming the challenge of lipid metabolic diseases in laying hens during the late laying period. ABSTRACT: The T329S mutation in flavin-containing monooxygenase 3 (FMO3) impairs the trimethylamine (TMA) metabolism in laying hens. The TMA metabolic pathway is closely linked to lipid metabolic diseases, such as atherosclerosis and fatty liver disease. We aimed to evaluate the effects of the T329S mutation in FMO3 on lipid metabolism in chickens during the late laying period. We selected 18 FMO3 genotyped individuals (consisting of six AA, six AT, and six TT hens) with similar body weight and production performance. The lipid metabolism and deposition characteristics of the laying hens with different genotypes were compared. The T329S mutation moderated the serum-lipid parameters in TT hens compared to those in AA and AT hens from 49 to 62 weeks. Furthermore, it reduced the serum trimethylamine N-oxide concentrations and increased the serum total bile acid (p < 0.05) and related lipid transporter levels in TT hens. Moreover, it significantly (p < 0.01) decreased atherosclerotic lesions and hepatic steatosis in TT hens compared to those in the AA and AT hens. Our findings may help improve the health status in laying hens during the late laying period.
format Online
Article
Text
id pubmed-8749748
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87497482022-01-12 T329S Mutation in the FMO3 Gene Alleviates Lipid Metabolic Diseases in Chickens in the Late Laying Period Song, Jianlou Huang, Mingyi Shi, Xuefeng Li, Xianyu Chen, Xia He, Zhaoxiang Li, Junying Xu, Guiyun Zheng, Jiangxia Animals (Basel) Article SIMPLE SUMMARY: The lipid deposition and health status of egg-laying hens is crucial to the development of the poultry industry. This study aimed to evaluate the effects of genetic variations in the flavin-containing monooxygenase 3 (FMO3) on the lipid metabolic diseases of laying hens during the late laying period. The results showed that the T329S mutation in FMO3 moderated the lipid parameters and decreased the atherosclerotic lesions and hepatic steatosis in laying hens with homozygous T329S mutation. In conclusion, the T329S mutation in FMO3 is closely associated with the improvement of lipid metabolic diseases in laying hens during the late laying period. The results of this study may contribute to overcoming the challenge of lipid metabolic diseases in laying hens during the late laying period. ABSTRACT: The T329S mutation in flavin-containing monooxygenase 3 (FMO3) impairs the trimethylamine (TMA) metabolism in laying hens. The TMA metabolic pathway is closely linked to lipid metabolic diseases, such as atherosclerosis and fatty liver disease. We aimed to evaluate the effects of the T329S mutation in FMO3 on lipid metabolism in chickens during the late laying period. We selected 18 FMO3 genotyped individuals (consisting of six AA, six AT, and six TT hens) with similar body weight and production performance. The lipid metabolism and deposition characteristics of the laying hens with different genotypes were compared. The T329S mutation moderated the serum-lipid parameters in TT hens compared to those in AA and AT hens from 49 to 62 weeks. Furthermore, it reduced the serum trimethylamine N-oxide concentrations and increased the serum total bile acid (p < 0.05) and related lipid transporter levels in TT hens. Moreover, it significantly (p < 0.01) decreased atherosclerotic lesions and hepatic steatosis in TT hens compared to those in the AA and AT hens. Our findings may help improve the health status in laying hens during the late laying period. MDPI 2021-12-27 /pmc/articles/PMC8749748/ /pubmed/35011153 http://dx.doi.org/10.3390/ani12010048 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Song, Jianlou
Huang, Mingyi
Shi, Xuefeng
Li, Xianyu
Chen, Xia
He, Zhaoxiang
Li, Junying
Xu, Guiyun
Zheng, Jiangxia
T329S Mutation in the FMO3 Gene Alleviates Lipid Metabolic Diseases in Chickens in the Late Laying Period
title T329S Mutation in the FMO3 Gene Alleviates Lipid Metabolic Diseases in Chickens in the Late Laying Period
title_full T329S Mutation in the FMO3 Gene Alleviates Lipid Metabolic Diseases in Chickens in the Late Laying Period
title_fullStr T329S Mutation in the FMO3 Gene Alleviates Lipid Metabolic Diseases in Chickens in the Late Laying Period
title_full_unstemmed T329S Mutation in the FMO3 Gene Alleviates Lipid Metabolic Diseases in Chickens in the Late Laying Period
title_short T329S Mutation in the FMO3 Gene Alleviates Lipid Metabolic Diseases in Chickens in the Late Laying Period
title_sort t329s mutation in the fmo3 gene alleviates lipid metabolic diseases in chickens in the late laying period
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749748/
https://www.ncbi.nlm.nih.gov/pubmed/35011153
http://dx.doi.org/10.3390/ani12010048
work_keys_str_mv AT songjianlou t329smutationinthefmo3genealleviateslipidmetabolicdiseasesinchickensinthelatelayingperiod
AT huangmingyi t329smutationinthefmo3genealleviateslipidmetabolicdiseasesinchickensinthelatelayingperiod
AT shixuefeng t329smutationinthefmo3genealleviateslipidmetabolicdiseasesinchickensinthelatelayingperiod
AT lixianyu t329smutationinthefmo3genealleviateslipidmetabolicdiseasesinchickensinthelatelayingperiod
AT chenxia t329smutationinthefmo3genealleviateslipidmetabolicdiseasesinchickensinthelatelayingperiod
AT hezhaoxiang t329smutationinthefmo3genealleviateslipidmetabolicdiseasesinchickensinthelatelayingperiod
AT lijunying t329smutationinthefmo3genealleviateslipidmetabolicdiseasesinchickensinthelatelayingperiod
AT xuguiyun t329smutationinthefmo3genealleviateslipidmetabolicdiseasesinchickensinthelatelayingperiod
AT zhengjiangxia t329smutationinthefmo3genealleviateslipidmetabolicdiseasesinchickensinthelatelayingperiod